XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2024
Stockholders’ Equity [Line Items]  
Schedule of Fair Values at the Commitment Date for the Warrants The fair values at the commitment date for the warrants were based upon the following management assumptions as of the date of issuance:
   Issuance
date		 
Risk-free interest rate   1.93%
Expected dividend yield   
-
%
Expected volatility   144%
Term    5 years 
Fair value of common stock  $1.41 

 
Schedule of Warrant and Stock Option Grants with Time-Based Vesting The number of shares of the Company’s common stock that are issuable pursuant to warrant and stock option grants with time-based vesting as of and for the nine months ended September 30, 2024 were:
   Warrant Grants   Stock Option Grants   Restricted
Stock
Units		 
   Number of
shares
subject to
warrants		   Weighted-
average
exercise
price per
share		   Number of
shares
subject to
options		   Weighted-
average
exercise
price per
share		   Number of
shares
subject to
restricted
stock units		 
Balance at December 31, 2023   11,394   $58.72    3,333   $39.60    165,663 
Granted   4,887,118    1.53    
-
    
-
    123,690 
Exercised   
-
    
-
    
-
    
-
    (125,357)
Cancelled/Expired   (2,293)   53.64    
-
    
-
    (41,722)
Balance at September 30, 2024   4,896,219   $1.64    3,333   $39.60    122,274 
Exercisable at September 30, 2024   4,896,219   $1.64    3,333   $39.60    122,274 
The number of shares of the Company’s common stock that are issuable pursuant to warrant and stock option grants with time-based vesting as of and for the nine months ended September 30, 2023 were:
   Warrant Grants   Stock Option Grants   Restricted
Stock
Units		 
   Number of
shares
subject to
warrants		   Weighted-
average
exercise
price per
share		   Number of
shares
subject to
options		   Weighted-
average
exercise
price per
share		   Number of
shares
subject to
restricted
stock units		 
Balance at December 31, 2022   104,515   $20.25    7,889   $48.75    160,650 
Granted   
-
    
-
    
-
    
-
    58,105 
Exercised   (54,872)   9.75    
-
    
-
    (47,706)
Cancelled/Expired   (4,812)   120.75    (1,222)   98.55    (4,610)
Balance at September 30, 2023   44,831   $22.20    6,667   $39.60    166,439 
Exercisable at September 30, 2023   44,831   $22.20    6,667   $39.60    162,606 
Schedule of Stock-Based Compensation Expense Stock-based compensation expense for three and nine months ended September 30, 2024 and 2023 is as follows:
   For the three months ended   For the nine months ended 
   September 30,   September 30, 
   2024   2023   2024   2023 
Stock-based compensation expense  $
      -
   $40,547   $
        -
   $336,293 
Warrant [Member]  
Stockholders’ Equity [Line Items]  
Schedule of Company’s Outstanding Warrants and Options The Company’s outstanding warrants and options at September 30, 2024 are as follows:
Warrants Outstanding   Warrants Exercisable 
Exercise Price
Range		   Number
Outstanding		    Weighted Average
Remaining
Contractual Life
(in years)		    Weighted
Average
Exercise Price		   Number
Exercisable		   Weighted
Average
Exercise Price		    Intrinsic
Value		 
$1.43 - $60.00   4,896,219    4.79   $1.64   4,896,219  $1.64    
        -
 
Options Outstanding   Options Exercisable 
Exercise Price
Range		  Number
Outstanding		   Weighted Average
Remaining
Contractual Life
(in years)		   Weighted
Average
Exercise Price		   Number
Exercisable		  Weighted
Average
Exercise Price		   Intrinsic
Value		 
$39.60   3,333    0.16   $39.60   3,333  $39.60    
   -